
| • |
Net sales increased 5.5 percent to a record $757.4 million.
|
| • |
Gross profit increased 16.1 percent to a record $153.8 million.
|
| • |
Generated cash from operating activities of $45.5 million and reduced net bank debt by $32.6 million to $81.4 million.
|
| • |
Repurchased 542,134 shares for $4.8 million.
|
|
Three Months Ended March 31,
|
Year Ended March 31,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
(Unaudited)
|
||||||||||||||||
|
Net sales
|
$
|
193,105,000
|
$
|
189,478,000
|
$
|
757,354,000
|
$
|
717,684,000
|
||||||||
|
Cost of goods sold
|
154,610,000
|
154,685,000
|
603,526,000
|
585,133,000
|
||||||||||||
|
Gross profit
|
38,495,000
|
34,793,000
|
153,828,000
|
132,551,000
|
||||||||||||
|
Operating expenses:
|
||||||||||||||||
|
General and administrative
|
16,113,000
|
15,644,000
|
64,047,000
|
57,769,000
|
||||||||||||
|
Sales and marketing
|
5,657,000
|
5,443,000
|
22,561,000
|
22,481,000
|
||||||||||||
|
Research and development
|
3,521,000
|
2,643,000
|
11,405,000
|
9,995,000
|
||||||||||||
|
Foreign exchange impact of lease liabilities and forward contracts
|
(3,074,000
|
)
|
(1,155,000
|
)
|
15,892,000
|
(3,814,000
|
)
|
|||||||||
|
Total operating expenses
|
22,217,000
|
22,575,000
|
113,905,000
|
86,431,000
|
||||||||||||
|
Operating income
|
16,278,000
|
12,218,000
|
39,923,000
|
46,120,000
|
||||||||||||
|
Other expenses:
|
||||||||||||||||
|
Interest expense, net
|
12,546,000
|
14,640,000
|
55,550,000
|
60,040,000
|
||||||||||||
|
Change in fair value of compound net derivative liability
|
2,520,000
|
(2,710,000
|
)
|
60,000
|
(1,020,000
|
)
|
||||||||||
|
Loss on extinguishment of debt
|
-
|
-
|
-
|
168,000
|
||||||||||||
|
Total other expenses
|
15,066,000
|
11,930,000
|
55,610,000
|
59,188,000
|
||||||||||||
|
Income (loss) before income tax expense (benefit)
|
1,212,000
|
288,000
|
(15,687,000
|
)
|
(13,068,000
|
)
|
||||||||||
|
Income tax expense (benefit)
|
1,934,000
|
(1,050,000
|
)
|
3,783,000
|
36,176,000
|
|||||||||||
|
Net (loss) income
|
$
|
(722,000
|
)
|
$
|
1,338,000
|
$
|
(19,470,000
|
)
|
$
|
(49,244,000
|
)
|
|||||
|
Basic net (loss) income per share
|
$
|
(0.04
|
)
|
$
|
0.07
|
$
|
(0.99
|
)
|
$
|
(2.51
|
)
|
|||||
|
Diluted net loss per share
|
$
|
(0.04
|
)
|
$
|
(0.03
|
)
|
$
|
(0.99
|
)
|
$
|
(2.51
|
)
|
||||
|
Weighted average number of shares outstanding:
|
||||||||||||||||
|
Basic
|
19,519,836
|
19,662,380
|
19,685,322
|
19,601,204
|
||||||||||||
|
Diluted
|
19,519,836
|
22,085,292
|
19,685,322
|
19,601,204
|
||||||||||||
|
March 31, 2025
|
March 31, 2024
|
|||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
9,429,000
|
$
|
13,974,000
|
||||
|
Short-term investments
|
1,881,000
|
1,837,000
|
||||||
|
Accounts receivable — net
|
91,064,000
|
96,296,000
|
||||||
|
Inventory — net
|
341,209,000
|
377,040,000
|
||||||
|
Inventory unreturned
|
18,460,000
|
20,288,000
|
||||||
|
Contract assets
|
29,606,000
|
27,139,000
|
||||||
|
Income tax receivable
|
4,208,000
|
5,683,000
|
||||||
|
Prepaid expenses and other current assets
|
15,614,000
|
18,202,000
|
||||||
|
Total current assets
|
511,471,000
|
560,459,000
|
||||||
|
Plant and equipment — net
|
31,990,000
|
38,338,000
|
||||||
|
Operating lease assets
|
66,603,000
|
83,973,000
|
||||||
|
Deferred income taxes
|
4,569,000
|
2,976,000
|
||||||
|
Long-term contract assets
|
336,268,000
|
320,282,000
|
||||||
|
Goodwill
|
3,205,000
|
3,205,000
|
||||||
|
Intangible assets — net
|
552,000
|
1,069,000
|
||||||
|
Other assets
|
2,978,000
|
1,700,000
|
||||||
|
TOTAL ASSETS
|
$
|
957,636,000
|
$
|
1,012,002,000
|
||||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$
|
141,906,000
|
$
|
154,977,000
|
||||
|
Accrued liabilities
|
30,211,000
|
30,205,000
|
||||||
|
Customer finished goods returns accrual
|
34,411,000
|
38,312,000
|
||||||
|
Contract liabilities
|
38,158,000
|
37,591,000
|
||||||
|
Revolving loan
|
90,787,000
|
128,000,000
|
||||||
|
Other current liabilities
|
5,570,000
|
7,021,000
|
||||||
|
Operating lease liabilities
|
9,982,000
|
8,319,000
|
||||||
|
Total current liabilities
|
351,025,000
|
404,425,000
|
||||||
|
Convertible notes, related party
|
35,207,000
|
30,776,000
|
||||||
|
Contract liabilities, less current portion
|
241,404,000
|
212,068,000
|
||||||
|
Deferred income taxes
|
362,000
|
511,000
|
||||||
|
Operating lease liabilities, less current portion
|
65,308,000
|
72,240,000
|
||||||
|
Other liabilities
|
6,631,000
|
6,872,000
|
||||||
|
Total liabilities
|
699,937,000
|
726,892,000
|
||||||
|
Commitments and contingencies
|
||||||||
|
Shareholders’ equity:
|
||||||||
|
Preferred stock; par value $.01 per share, 5,000,000 shares authorized; none issued
Series A junior participating preferred stock; par value $.01 per share,
|
-
|
-
|
||||||
|
20,000 shares authorized; none issued Common stock; par value $.01 per share, 50,000,000 shares authorized;
|
-
|
-
|
||||||
|
19,435,706 and 19,662,380 shares issued and outstanding at March 31, 2025 and 2024, respectively
|
194,000
|
197,000
|
||||||
|
Additional paid-in capital
|
234,413,000
|
236,255,000
|
||||||
|
Retained earnings
|
20,033,000
|
39,503,000
|
||||||
|
Accumulated other comprehensive income
|
3,059,000
|
9,155,000
|
||||||
|
Total shareholders’ equity
|
257,699,000
|
285,110,000
|
||||||
|
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
|
$
|
957,636,000
|
$
|
1,012,002,000
|
||||
| Items Impacting Net Income for the Three Months Ended March 31, 2025 and 2024 | Exhibit 1 |
|
Three Months Ended March 31,
|
||||||||||||||||
|
2025
|
2024
|
|||||||||||||||
| |
$ |
Per Diluted
Share
|
|
$ |
Per Diluted
Share
|
|||||||||||
|
GAAP net (loss) income
|
$
|
(722,000
|
)
|
$
|
(0.04
|
)
|
$
|
1,338,000
|
$
|
(0.03
|
)
|
|||||
|
Non-cash items impacting net income
|
||||||||||||||||
|
Core and finished goods premium amortization
|
$
|
2,725,000
|
$
|
0.14
|
$
|
2,761,000
|
$
|
0.13
|
||||||||
|
Revaluation - cores on customers’ shelves
|
489,000
|
0.03
|
973,000
|
0.04
|
||||||||||||
|
Share-based compensation expenses
|
868,000
|
0.04
|
432,000
|
0.02
|
||||||||||||
|
Foreign exchange impact of lease liabilities and forward contracts
|
(3,074,000
|
)
|
(0.16
|
)
|
(1,155,000
|
)
|
(0.05
|
)
|
||||||||
|
Change in fair value of compound net derivative liability
|
2,520,000
|
0.13
|
(2,710,000
|
)
|
(0.12
|
)
|
||||||||||
|
Tax effect (a)
|
(882,000
|
)
|
(0.05
|
)
|
(75,000
|
)
|
(0.00
|
)
|
||||||||
|
Tax valuation allowance
|
-
|
-
|
548,000
|
0.02
|
||||||||||||
|
Total non-cash items impacting net income
|
$
|
2,646,000
|
$
|
0.14
|
$
|
774,000
|
$
|
0.04
|
||||||||
|
Cash items impacting net income
|
||||||||||||||||
|
Supply chain disruptions and related costs (b)
|
$
|
-
|
$
|
-
|
$
|
734,000
|
$
|
0.03
|
||||||||
|
New product line start-up costs and transition expenses, and severance and other (c)
|
160,000
|
0.01
|
840,000
|
0.04
|
||||||||||||
|
Tariff costs paid for products sold before price increases were effective
|
4,607,000
|
0.24
|
-
|
-
|
||||||||||||
|
Tax effect (a)
|
(1,192,000
|
)
|
(0.06
|
)
|
(394,000
|
)
|
(0.02
|
)
|
||||||||
|
Total cash items impacting net income
|
$
|
3,575,000
|
$
|
0.18
|
$
|
1,180,000
|
$
|
0.05
|
||||||||
| Items Impacting Net Income for the Twelve Months Ended March 31, 2025 and 2024 | Exhibit 2 |
|
Twelve Months Ended March 31,
|
||||||||||||||||
|
2025
|
2024
|
|||||||||||||||
| $ |
Per Diluted
Share
|
$ |
Per Diluted
Share
|
|||||||||||||
|
GAAP net loss
|
$
|
(19,470,000
|
)
|
$
|
(0.99
|
)
|
$
|
(49,244,000
|
)
|
$
|
(2.51
|
)
|
||||
|
Non-cash items impacting net income
|
||||||||||||||||
|
Core and finished goods premium amortization
|
$
|
10,738,000
|
$
|
0.55
|
$
|
10,963,000
|
$
|
0.56
|
||||||||
|
Revaluation - cores on customers’ shelves
|
2,805,000
|
0.14
|
5,353,000
|
0.27
|
||||||||||||
|
Share-based compensation expenses
|
3,877,000
|
0.20
|
4,700,000
|
0.24
|
||||||||||||
|
Foreign exchange impact of lease liabilities and forward contracts
|
15,892,000
|
0.81
|
(3,814,000
|
)
|
(0.19
|
)
|
||||||||||
|
Change in fair value of compound net derivative liability and loss on extinguishment of debt
|
60,000
|
0.00
|
(852,000
|
)
|
(0.04
|
)
|
||||||||||
|
Tax effect (a)
|
(8,343,000
|
)
|
(0.42
|
)
|
(4,088,000
|
)
|
(0.21
|
)
|
||||||||
|
Tax valuation allowance
|
-
|
-
|
38,009,000
|
1.94
|
||||||||||||
|
Total non-cash items impacting net income
|
$
|
25,029,000
|
$
|
1.27
|
$
|
50,271,000
|
$
|
2.56
|
||||||||
|
Cash items impacting net income
|
||||||||||||||||
|
Supply chain disruptions and related costs (b)
|
$
|
-
|
$
|
-
|
$
|
7,472,000
|
$
|
0.38
|
||||||||
|
New product line start-up costs and transition expenses, and severance and other (c)
|
4,598,000
|
0.23
|
1,820,000
|
0.09
|
||||||||||||
|
Tariff costs paid for products sold before price increases were effective
|
4,607,000
|
0.23
|
-
|
-
|
||||||||||||
|
Tax effect (a)
|
(2,301,000
|
)
|
(0.12
|
)
|
(2,323,000
|
)
|
(0.12
|
)
|
||||||||
|
Total cash items impacting net income
|
$
|
6,904,000
|
$
|
0.35
|
$
|
6,969,000
|
$
|
0.36
|
||||||||
| Items Impacting Gross Profit for the Three Months Ended March 31, 2025 and 2024 | Exhibit 3 |
|
Three Months Ended March 31,
|
||||||||||||||||
|
2025
|
2024
|
|||||||||||||||
|
|
$ |
Gross
Margin
|
|
$ |
Gross
Margin
|
|||||||||||
|
GAAP gross profit
|
$
|
38,495,000
|
19.9
|
%
|
$
|
34,793,000
|
18.4
|
%
|
||||||||
|
Non-cash items impacting gross profit
|
||||||||||||||||
|
Core and finished goods premium amortization
|
$
|
2,725,000
|
1.4
|
%
|
$
|
2,761,000
|
1.5
|
%
|
||||||||
|
Revaluation - cores on customers’ shelves
|
489,000
|
0.3
|
%
|
973,000
|
0.5
|
%
|
||||||||||
|
Total non-cash items impacting gross profit
|
$
|
3,214,000
|
1.7
|
%
|
$
|
3,734,000
|
2.0
|
%
|
||||||||
|
Cash items impacting gross profit
|
||||||||||||||||
|
Supply chain disruptions and related costs
|
$
|
-
|
-
|
$
|
734,000
|
0.4
|
%
|
|||||||||
|
Tariff costs paid for products sold before price increases were effective
|
4,607,000
|
2.4
|
%
|
-
|
-
|
|||||||||||
|
Total cash items impacting gross profit
|
$
|
4,607,000
|
2.4
|
%
|
$
|
734,000
|
0.4
|
%
|
||||||||
|
Items Impacting Gross Profit for the Twelve Months Ended March 31, 2025 and 2024
|
Exhibit 4 |
|
Twelve Months Ended March 31,
|
||||||||||||||||
|
2025
|
2024
|
|||||||||||||||
|
|
$ |
Gross Margin
|
|
$ |
Gross Margin
|
|||||||||||
|
GAAP gross profit
|
$
|
153,828,000
|
20.3
|
%
|
$
|
132,551,000
|
18.5
|
%
|
||||||||
|
Non-cash items impacting gross profit
|
||||||||||||||||
|
Core and finished goods premium amortization
|
$
|
10,738,000
|
1.4
|
%
|
$
|
10,963,000
|
1.5
|
%
|
||||||||
|
Revaluation - cores on customers’ shelves
|
2,805,000
|
0.4
|
%
|
5,353,000
|
0.7
|
%
|
||||||||||
|
Total non-cash items impacting gross profit
|
$
|
13,543,000
|
1.8
|
%
|
$
|
16,316,000
|
2.3
|
%
|
||||||||
|
Cash items impacting gross profit
|
||||||||||||||||
|
Supply chain disruptions and related costs
|
$
|
-
|
-
|
$
|
7,472,000
|
1.0
|
%
|
|||||||||
|
New product line start-up costs and transition expenses
|
1,298,000
|
0.2
|
%
|
-
|
-
|
|||||||||||
|
Tariff costs paid for products sold before price increases were effective
|
4,607,000
|
0.6
|
%
|
-
|
-
|
|||||||||||
|
Total cash items impacting gross profit
|
$
|
5,905,000
|
0.8
|
%
|
$
|
7,472,000
|
1.0
|
%
|
||||||||
|
Items Impacting EBITDA for the Three and Twelve Months Ended March 31, 2025 and 2024
|
Exhibit 5 |
|
Three Months Ended March 31,
|
Twelve Months Ended March 31,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
GAAP net (loss) income
|
$
|
(722,000
|
)
|
$
|
1,338,000
|
$
|
(19,470,000
|
)
|
$
|
(49,244,000
|
)
|
|||||
|
Interest expense, net
|
12,546,000
|
14,640,000
|
55,550,000
|
60,040,000
|
||||||||||||
|
Income tax expense (benefit)
|
1,934,000
|
(1,050,000
|
)
|
3,783,000
|
36,176,000
|
|||||||||||
|
Depreciation and amortization
|
2,538,000
|
2,775,000
|
10,400,000
|
11,619,000
|
||||||||||||
|
EBITDA
|
$
|
16,296,000
|
$
|
17,703,000
|
$
|
50,263,000
|
$
|
58,591,000
|
||||||||
|
Non-cash items impacting EBITDA
|
||||||||||||||||
|
Core and finished goods premium amortization
|
$
|
2,725,000
|
$
|
2,761,000
|
$
|
10,738,000
|
$
|
10,963,000
|
||||||||
|
Revaluation - cores on customers’ shelves
|
489,000
|
973,000
|
2,805,000
|
5,353,000
|
||||||||||||
|
Share-based compensation expenses
|
868,000
|
432,000
|
3,877,000
|
4,700,000
|
||||||||||||
|
Foreign exchange impact of lease liabilities and forward contracts
|
(3,074,000
|
)
|
(1,155,000
|
)
|
15,892,000
|
(3,814,000
|
)
|
|||||||||
|
Change in fair value of compound net derivative liability and loss on extinguishment of debt
|
2,520,000
|
(2,710,000
|
)
|
60,000
|
(852,000
|
)
|
||||||||||
|
Total non-cash items impacting EBITDA
|
$
|
3,528,000
|
$
|
301,000
|
$
|
33,372,000
|
$
|
16,350,000
|
||||||||
|
Cash items impacting EBITDA
|
||||||||||||||||
|
Supply chain disruptions and related costs
|
$
|
-
|
$
|
734,000
|
$
|
-
|
$
|
7,472,000
|
||||||||
|
New product line start-up costs and transition expenses, and severance and other
|
160,000
|
840,000
|
4,598,000
|
1,820,000
|
||||||||||||
|
Tariff costs paid for products sold before price increases were effective
|
4,607,000
|
-
|
4,607,000
|
-
|
||||||||||||
|
Total cash items impacting EBITDA
|
$
|
4,767,000
|
$
|
1,574,000
|
$
|
9,205,000
|
$
|
9,292,000
|
||||||||